EKE Programma’s Een lijst met de beschikbare EKE programma’s van QCMD wordt hieronder weergegeven. Voor verdere informatie of om in te schrijven op een EKE programma, log in in uw persoonlijk QCMD Profiel. Als u geen gebruikersnaam en paswoord hebt klik hier. Blood Borne Virus Click to view/hide EQA Programme   Analysis Type Shipping Conditions HIV-1 (DNA)   Qualitative Dry-ice B19 Virus   Qualitative & Quantitative Dry-ice HCV Genotyping Molecular Typing Dry-ice HBV Genotyping Molecular Typing Dry-ice HIV-1 Drug Resistance Sequencing Ambient HIV-1 Drug Resistance (Integrase) Sequencing Ambient Hepatitis A virus   Qualitative & Quantitative Dry-ice Hepatitis E virus   Qualitative & Quantitative Dry-ice HBV Drug Resistance Sequencing Dry-ice HCV Drug Resistance Sequencing Dry-ice HIV-1 (RNA)   Qualitative & Quantitative Dry-ice HIV-1 RNA regulatory programme   Qualitative & Quantitative Dry-ice Hepatitis B virus   Qualitative & Quantitative Dry-ice HBV regulatory programme   Qualitative & Quantitative Dry-ice Hepatitis C virus   Qualitative & Quantitative Dry-ice HCV regulatory programme   Qualitative & Quantitative Dry-ice Central Nervous System Click to view/hide EQA Programme   Analysis Type Shipping Conditions Varicella-Zoster virus   Qualitative & Quantitative Ambient Enterovirus   Qualitative & Quantitative Ambient Parechovirus   Qualitative & Quantitative Ambient Herpes simplex virus 1 & 2 Qualitative & Quantitative Ambient West Nile Virus Qualitative Ambient Dengue Virus Qualitative Ambient JC virus and BK virus Qualitative & Quantitative Dry-ice Toxoplasma gondii Qualitative Ambient Borrelia burgdorferi (Lyme's disease)   Qualitative Dry-ice Congenital Infections Click to view/hide EQA Programme   Analysis Type Shipping Conditions Cytomegalovirus Dried Blood Spots   Qualitative & Quantitative Dry-ice Toxoplasma gondii Qualitative Ambient Drug Resistance Click to view/hide EQA Programme   Analysis Type Shipping Conditions Methicillin Resistant S. aureus   Qualitative Ambient HIV-1 Drug Resistance Sequencing Ambient HIV-1 Drug Resistance (Integrase) Sequencing Ambient Extended Spectrum ß-lactamase   Qualitative Dry-ice Vancomycin Resistant Enterococci   Qualitative Dry-ice Methicillin Resistant S. aureus SPA Sequencing Dry-ice HBV Drug Resistance Sequencing Dry-ice HCV Drug Resistance Sequencing Dry-ice Exotic / Emerging Diseases Click to view/hide EQA Programme   Analysis Type Shipping Conditions West Nile Virus Qualitative Ambient Dengue Virus Qualitative Ambient Gastrointestinal Diseases Click to view/hide EQA Programme   Analysis Type Shipping Conditions Clostridium difficile   Qualitative Ambient Adenovirus Qualitative & Quantitative Dry-ice Norovirus   Qualitative Dry-ice Viral Gastroenteritis   Qualitative Dry-ice Bacterial Gastroenteritis   Qualitative Dry-ice Parasitic Gastroenteritis   Qualitative Dry-ice Immunocompromised Associated Diseases Click to view/hide EQA Programme   Analysis Type Shipping Conditions JC virus and BK virus Qualitative & Quantitative Dry-ice Human Herpes Virus 6 Qualitative & Quantitative Dry-ice Human Cytomegalovirus Qualitative & Quantitative Dry-ice Human Cytomegalovirus Whole Blood Qualitative & Quantitative Dry-ice Epstein-Barr virus Qualitative & Quantitative Dry-ice Epstein-Barr virus Whole Blood Qualitative & Quantitative Dry-ice Toxoplasma gondii Qualitative Ambient Aspergillus   Qualitative Dry-ice Candida spp   Qualitative Dry-ice Pneumocystis jirovecii pneumonia (PCP) Qualitative Dry-ice Respiratory Diseases Click to view/hide EQA Programme   Analysis Type Shipping Conditions Chlamydophila pneumoniae and Mycoplasma pneumoniae   Qualitative Ambient Legionella pneumophila   Qualitative Ambient M. tuberculosis Complex   Qualitative Ambient Bordetella pertussis   Qualitative & Quantitative Dry-ice Adenovirus Qualitative & Quantitative Dry-ice Influenza A & B virus   Qualitative Dry-ice Human Metapneumovirus   Qualitative Dry-ice Respiratory Syncytial Virus   Qualitative Dry-ice Parainfluenza virus   Qualitative Dry-ice Coronavirus   Qualitative Dry-ice Rhinovirus   Qualitative Dry-ice Influenza Haemagglutinin Typing Molecular typing Dry-ice Chlamydia psittaci   Qualitative Dry-ice Pneumocystis jirovecii pneumonia (PCP) Qualitative Dry-ice Sexually Transmitted Infections Click to view/hide EQA Programme   Analysis Type Shipping Conditions Chlamydia trachomatis   Qualitative Ambient Herpes simplex virus 1 & 2 Qualitative & Quantitative Ambient Neisseria gonorrhoeae   Qualitative Ambient Human Papillomavirus   Qualitative Ambient Transplant Associated Diseases Click to view/hide EQA Programme   Analysis Type Shipping Conditions JC virus and BK virus Qualitative & Quantitative Dry-ice Human Herpes Virus 6 Qualitative & Quantitative Dry-ice Human Cytomegalovirus Qualitative & Quantitative Dry-ice Human Cytomegalovirus Whole Blood Qualitative & Quantitative Dry-ice Epstein-Barr virus Qualitative & Quantitative Dry-ice Epstein-Barr virus Whole Blood Qualitative & Quantitative Dry-ice Toxoplasma gondii Qualitative Ambient Adenovirus Qualitative & Quantitative Dry-ice Typing Click to view/hide EQA Programme   Analysis Type Shipping Conditions HCV Genotyping Molecular Typing Dry-ice HBV Genotyping Molecular Typing Dry-ice Methicillin Resistant S. Aureus Typing   Molecular Typing Ambient HIV-1 Drug Resistance Sequencing Ambient HIV-1 Drug Resistance (Integrase) Sequencing Ambient Methicillin Resistant S. aureus SPA Qualitative Dry-ice HBV Drug Resistance Sequencing Dry-ice HCV Drug Resistance Sequencing Dry-ice Influenza Haemagglutinin Typing Molecular Typing Dry-ice MALDI-TOF Bacterial   Qualitative Dry-ice Unit 5, Technology Terrace, Todd Campus, West of Scotland Science Park Glasgow G20 0XA Scotland, UK Tel: +44 (0)141 945 6474 Fax: +44 (0)141 945 5795 Contact Us